Q4 2018 Holdings
Filed 2019-02-14 | 24 holdings | $551.6M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2019-08-22) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $391.6M | 11,925,419 | 71.0% |
| Agios Pharmaceuticals Inc(AGIO) | Common | 00847X104 | $91.2M | 1,977,459 | 16.5% |
| Biogen Inc(BIIB) | Common | 09062X103 | $68.2M | 226,564 | 12.4% |
| Theravance Biopharma Inc(TBPH) | Common | G8807B106 | $315.2K | 12,316,529 | 0.1% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $122.8K | 11,924,614 | 0.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $77.9K | 2,639,676 | 0.0% |
| Evofem Biosciences Inc(NEOTEUR) | Common | 30048L104 | $40.2K | 9,593,197 | 0.0% |
| Nucana PLC | SPON ADR | 67022C106 | $27.0K | 1,865,000 | 0.0% |
| Nightstar Therapeutics PLC | ADR | 65413A101 | $22.1K | 1,921,315 | 0.0% |